Corrigendum to “Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss” [FEBS Lett. 580 (2006) 1251-1256]

FEBS Letters ◽  
2006 ◽  
Vol 580 (27) ◽  
pp. 6519-6519
Author(s):  
Shigeki Oshima ◽  
Shin Onodera ◽  
Norio Amizuka ◽  
Minqi Li ◽  
Kazuharu Irie ◽  
...  
FEBS Letters ◽  
2006 ◽  
Vol 580 (5) ◽  
pp. 1251-1256 ◽  
Author(s):  
Shigeki Oshima ◽  
Shin Onodera ◽  
Norio Amizuka ◽  
Minqi Li ◽  
Kazuharu Irie ◽  
...  

Bone ◽  
2010 ◽  
Vol 47 (2) ◽  
pp. 424-429 ◽  
Author(s):  
Maria Swanberg ◽  
Fiona McGuigan ◽  
Kaisa K. Ivaska ◽  
Paul Gerdhem ◽  
Ulf H. Lerner ◽  
...  

Vaccine ◽  
2008 ◽  
Vol 26 (6) ◽  
pp. 829-836 ◽  
Author(s):  
Shin Onodera ◽  
Shigeki Oshima ◽  
Jun Nishihira ◽  
Kazunori Yasuda ◽  
Harukazu Tohyama ◽  
...  

2010 ◽  
Vol 22 (6) ◽  
pp. 1955-1965 ◽  
Author(s):  
T. Kobayashi ◽  
S. Onodera ◽  
E. Kondo ◽  
H. Tohyama ◽  
H. Fujiki ◽  
...  

2013 ◽  
Vol 65 (2) ◽  
pp. 499-505 ◽  
Author(s):  
Tamara Saksida ◽  
Stanislava Stosic-Grujicic ◽  
Ivana Stojanovic

Macrophage migration inhibitory factor (MIF) is implicated in the pathogenesis of several inflammationrelated diseases, including obesity and type 2 diabetes (T2D). However, MIF deficiency itself promotes obesity and glucose intolerance in mice. Here we show that the introduction of a high-fat diet (HFD) further aggravates the parameters of obesity-associated T2D: weight gain and glucose intolerance. Furthermore, in contrast to MIF-KO mice on standard chow, HFD-fed MIF-KO mice develop insulin resistance. Although the clinical signs of obesity-associated T2D are upgraded, inflammation in MIF-deficient mice on HFD is significantly lower. These results imply that MIF possesses a complex role in glucose metabolism and the development of obesity-related T2D. However, the downregulation of inflammation upon MIF inhibition could be a useful tool in short-term T2D therapy for preventing pancreatic islet deterioration.


Sign in / Sign up

Export Citation Format

Share Document